Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated125%
completed125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
terminatednot_applicable

Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD

NCT03901534
recruitingnot_applicable

Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial)

NCT05473689
recruitingnot_applicable

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI

NCT04007380
completed

Obstructive Sleep Apnea (OSA), Hypertension , β1 Subunit of Maxi-k+ Channel and Cardiovascular Risk

NCT01791270

Clinical Trials (4)

Showing 4 of 4 trials
NCT03901534Not Applicable

Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD

Terminated
NCT05473689Not Applicable

Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial)

Recruiting
NCT04007380Not Applicable

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI

Recruiting
NCT01791270

Obstructive Sleep Apnea (OSA), Hypertension , β1 Subunit of Maxi-k+ Channel and Cardiovascular Risk

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4